Coronavirus breakthrough: dexamethasone is first drug shown to save lives.

作者信息

Ledford Heidi

出版信息

Nature. 2020 Jun;582(7813):469. doi: 10.1038/d41586-020-01824-5.

DOI:10.1038/d41586-020-01824-5

PMID:32546811

Abstract

摘要

相似文献

[1]

Coronavirus breakthrough: dexamethasone is first drug shown to save lives.

Nature. 2020-6

[2]

Audio Interview: New Data on Remdesivir in Covid-19.

N Engl J Med. 2020-5-28

[3]

Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.

JAMA. 2020-6-16

[4]

Missed Opportunities on Emergency Remdesivir Use.

JAMA. 2020-7-28

[5]

Race to find COVID-19 treatments accelerates.

Science. 2020-3-27

[6]

A Proposed Lottery System to Allocate Scarce COVID-19 Medications: Promoting Fairness and Generating Knowledge.

JAMA. 2020-7-28

[7]

Communicating Science in the Time of a Pandemic.

JAMA. 2020-8-4

[8]

When the Others Become Us: A Chemist's Perspective of the COVID-19 Outbreak in Italy.

ACS Chem Biol. 2020-6-19

[9]

[Remdesivir for patients with COVID-19].

Internist (Berl). 2020-8

[10]

Arguments in favour of remdesivir for treating SARS-CoV-2 infections.

Int J Antimicrob Agents. 2020-4

引用本文的文献

[1]

Translational Success and Pharmacoeconomic Lessons of Pandemic-Driven Drug Repurposing.

Cureus. 2025-5-29

[2]

Antiviral nanomedicine: Advantages, mechanisms and advanced therapies.

Bioact Mater. 2025-6-5

[3]

Dexamethasone disrupts intracellular pH homeostasis to delay coronavirus infectious bronchitis virus cell entry via sodium hydrogen exchanger 3 activation.

J Virol. 2025-6-17

[4]

Increased circulating levels of SP-D and IL-10 are associated with the development of disease severity and pulmonary fibrosis in patients with COVID-19.

Front Immunol. 2025-3-14

[5]

Deep learning in the discovery of antiviral peptides and peptidomimetics: databases and prediction tools.

Mol Divers. 2025-3-28

[6]

Apoptotic body based biomimetic hybrid nanovesicles to attenuate cytokine storms for sepsis treatment.

J Nanobiotechnology. 2024-12-19

[7]

Strongyloides Hyperinfection Syndrome Following Immunosuppressant Therapy for COVID-19: A Case Report With Literature Review.

Clin Case Rep. 2024-12-6

[8]

A GPT-based EHR modeling system for unsupervised novel disease detection.

J Biomed Inform. 2024-9

[9]

A real-world pharmacovigilance study of polatuzumab vedotin based on the FDA adverse event reporting system (FAERS).

Front Pharmacol. 2024-6-25

[10]

Glucocorticoids-based prodrug design: Current strategies and research progress.

Asian J Pharm Sci. 2024-6

本文引用的文献

[1]

Remdesivir for the Treatment of Covid-19 - Final Report.

N Engl J Med. 2020-10-8

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Coronavirus breakthrough: dexamethasone is first drug shown to save lives.

作者信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献